Analytical Overview: Dyne Therapeutics Inc (DYN)’s Ratios Tell a Financial Story

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

As of close of business last night, Dyne Therapeutics Inc’s stock clocked out at $11.41, up 1.02% from its previous closing price of $11.30. In other words, the price has increased by $1.02 from its previous closing price. On the day, 4.52 million shares were traded.

Ratios:

To gain a deeper understanding of DYN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.35 and its Current Ratio is at 20.35. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on March 12, 2025, initiated with a Outperform rating and assigned the stock a target price of $50.

On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $50.

On December 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $46.Robert W. Baird initiated its Outperform rating on December 13, 2024, with a $46 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 13 ’25 when Friedl-Naderer Johanna sold 143 shares for $12.12 per share. The transaction valued at 1,733 led to the insider holds 96,057 shares of the business.

Scalzo Richard William sold 1,343 shares of DYN for $15,283 on Mar 11 ’25. The SVP, Head of Finance & Admin. now owns 122,330 shares after completing the transaction at $11.38 per share. On Mar 11 ’25, another insider, Beskrovnaya Oxana, who serves as the Chief Scientific Officer of the company, sold 2,153 shares for $11.38 each. As a result, the insider received 24,501 and left with 195,840 shares of the company.

Stock Price History:

Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 6.90%, while the 200-Day Moving Average is calculated to be -53.77%.

Shares Statistics:

A total of 113.63M shares are outstanding, with a floating share count of 87.75M. Insiders hold about 22.80% of the company’s shares, while institutions hold 78.39% stake in the company.

Most Popular